Hypera S.A. logo

Hypera S.A. (HYPE3)

Market Open
31 Mar, 19:55
B3 B3
R$
19. 37
-0.39
-1.97%
R$
13.08B Market Cap
11.13 P/E Ratio
0.09% Div Yield
2,455,600 Volume
0 Eps
R$ 19.76
Previous Close
Day Range
19.23 19.63
Year Range
16.62 33.06

Summary

HYPE3 trading today lower at R$19.37, a decrease of 1.97% from yesterday's close, completing a monthly increase of 3.92% or R$0.73. Over the past 12 months, HYPE3 stock gained 8.39%.
HYPE3 pays dividends to its shareholders, with the most recent payment made on Dec 31, 2024. The next announced payment will be in In 8 months on Dec 31, 2025 for a total of R$0.09735.
The last earnings report, released on Oct 26, 2023, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.2%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on B3 (BRL).
Want to track HYPE3 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

HYPE3 Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.

Hypera S.A. Dividends

Hypera S.A. logo
HYPE3 5 days ago
Estimated
Other
R$0.29 Per Share
Hypera S.A. logo
HYPE3 5 days ago
Other
R$0.29 Per Share
Hypera S.A. logo
HYPE3 3 months ago
Other
R$0.29 Per Share
Hypera S.A. logo
HYPE3 6 months ago
Other
R$0.2 Per Share
Hypera S.A. logo
HYPE3 8 months ago
Announced
Other
R$0.1 Per Share
Hypera S.A. logo
HYPE3 10 months ago
Announced
Other
R$0.1 Per Share

Hypera S.A. Earnings

26 Oct 2023 Date
-
Cons. EPS
-
EPS
31 Oct 2016 Date
-
Cons. EPS
0.32
EPS
25 Jul 2016 Date
-
Cons. EPS
0.27
EPS
27 Apr 2016 Date
-
Cons. EPS
1.57
EPS
22 Feb 2016 Date
-
Cons. EPS
0.45
EPS
Hypera S.A. logo
HYPE3 5 days ago
Estimated
Other
R$0.29 Per Share
Hypera S.A. logo
HYPE3 5 days ago
Other
R$0.29 Per Share
Hypera S.A. logo
HYPE3 3 months ago
Other
R$0.29 Per Share
Hypera S.A. logo
HYPE3 6 months ago
Other
R$0.2 Per Share
Hypera S.A. logo
HYPE3 8 months ago
Announced
Other
R$0.1 Per Share
Hypera S.A. logo
HYPE3 10 months ago
Announced
Other
R$0.1 Per Share
26 Oct 2023 Date
-
Cons. EPS
-
EPS
31 Oct 2016 Date
-
Cons. EPS
0.32
EPS
25 Jul 2016 Date
-
Cons. EPS
0.27
EPS
27 Apr 2016 Date
-
Cons. EPS
1.57
EPS
22 Feb 2016 Date
-
Cons. EPS
0.45
EPS

Hypera S.A. (HYPE3) FAQ

What is the stock price today?

The current price is R$19.37.

On which exchange is it traded?

Hypera S.A. is listed on B3.

What is its stock symbol?

The ticker symbol is HYPE3.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 13.08B.

Has Hypera S.A. ever had a stock split?

No, there has never been a stock split.

Hypera S.A. Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Mr. Breno Toledo Pires de Oliveira CEO
B3 Exchange
BRHYPEACNOR0 ISIN
Brazil Country
10,301 Employees
27 Mar 2025 Last Dividend
4 Jan 2010 Last Split
- IPO Date

Overview

Hypera S.A. is a prominent pharmaceutical company based in Brazil, known for its expansive portfolio of healthcare products. Initially established in 2001 under the name Hypermarcas S.A., the company underwent a name change to Hypera S.A. in February 2018, signifying a new era in its history. Operating primarily within Brazil, Hypera S.A. specializes in developing, producing, and marketing a wide range of pharmaceutical products, including prescription medications, over-the-counter (OTC) drugs, and nutritional supplements. Its mission centers on delivering high-quality healthcare solutions to improve the well-being of its consumer base. Headquartered in São Paulo, Brazil, Hypera S.A. stands as a leading entity in the Latin American pharmaceutical landscape.

Products and Services

Hypera S.A. offers an extensive variety of products and services categorized into several segments: pharmaceuticals, consumer health products, and nutritional and vitamin supplements. Listed below are some of the company's notable products and brands:

  • Pharmaceutical Products: The company's strong pharmaceutical portfolio includes prescription medications like Adacne, Addera, Celestamine, and Diprosone among others, catering to various healthcare needs from dermatological solutions to anti-inflammatory agents. They also offer a range of products such as Deciprax, Emprol XR, and Max Sulid, focusing on providing comprehensive healthcare remedies.
  • Sun Protection and Skincare: Under the Mantecorp Skincare brand, Hypera S.A. provides a spectrum of sun protection and moisturizing skin care products, addressing the growing consumer needs for comprehensive dermatological care and protection against harmful UV rays.
  • Consumer Health Products: The company's consumer health sector is symbolized by household names like Apracur, Benegrip, and Neosaldina, catering to everyday health issues such as cold and flu, digestive discomfort, and pain relief. The Neo Química brand is renowned for offering a range of similar and generic drugs, expanding the company’s reach in the consumer health market.
  • Nutritional and Vitamin Supplements: Recognizing the importance of dietary supplements in modern healthcare, Hypera S.A. markets products under the Tamarine, Vitasay, and Zero-Cal brands. These offer solutions for nutritional deficiencies and support overall health and wellness.
  • Generic Medicines: Emphasizing accessibility and affordability, Hypera S.A. provides a wide array of generic medicines including Hydroxyzine, Naproxene, and Omeprazole. This segment ensures patients have access to essential medications at lower costs while maintaining high-quality standards.

Contact Information

Address: Av. Magalhães de Castro, 4800
Phone: 55 11 3627 4206